改善帕金森病二次诊断的住院患者的药物管理
Arlene Boudreaux1, Ryan F Schell, Scott D Nelson
1Arlene Boudreaux is a clinical nurse specialist at Vanderbilt University Medical Center, Nashville, TN, where Ryan F. Schell is a clinical pharmacy manager, Scott D. Nelson and Fenna Phibbs are associate professors, Jessica Stroh is a patient care coordinator, and Amanda Fraley Depp is a clinical pharmacist. Contact author: Arlene Boudreaux, arlene.boudreaux@yahoo.com . The authors have disclosed no potential conflicts of interest, financial or otherwise.
The American journal of nursing
|April 25, 2024
概括
一个质量改善项目改善了医院中帕金森病患者的药物管理. 药房主导的药物历史减少了住院时间,死亡率,跌倒和再入院,同时提高了患者满意度.
科学领域:
- 神经学 神经学
- 医院管理局 医院管理局
- 提高质量 提高质量
背景情况:
- 帕金森病患者需要个性化药物治疗方案以获得最佳护理.
- 住院治疗往往会导致帕金森病患者的药物治疗方案偏差.
- 标准的医院实践可以增加帕金森病患者的跌倒,妄想和死亡率等风险.
研究的目的:
- 实施一个质量改进项目,重点是优化住院帕金森病患者的药物管理.
- 识别帕金森病患者 (包括二次诊断和深度大脑刺激) 并定制他们的药物治疗.
- 为了减少停留时间,死亡率,跌倒,跌倒伤害和30天再入院,同时评估患者满意度.
主要方法:
- 由护士领导的多学科团队 (药学,护理,信息学,神经学,质量) 从2020年7月到2022年7月进行了一项质量改进项目.
- 专注于识别帕金森病患者和定制药物管理.
- 评估药物使用史,停留时间,死亡率,跌倒,再入院和患者满意度.
主要成果:
- 药房主导的药物历史从53%增加到超过75%的二次诊断帕金森病患者.
- 订单与家庭疗法匹配89%的时间与药房参与相比,没有40%的时间.
- 观察到停留时间,死亡率,跌倒 (有和没有伤害) 和30天再入院的显著减少. 患者满意度得分提高了1.95分.
结论:
- 定制化,药房涉及的药物管理显著改善了住院帕金森病患者的治疗结果.
- 这种方法减少了不良事件和医疗保健利用率,提高了患者的安全和满意度.
- 多学科合作是成功提高专业患者护理质量的关键.
相关概念视频
01:24Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
01:15Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:26Psychosis: Goals of Pharmacotherapy
124
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
124
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.8K
01:28Pneumonia IV: Management
323
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
323